 Lisa Spencer
Concepts (273)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eosinophils | 34 | 2024 | 332 | 7.990 |
Why?
| | Enteritis | 6 | 2024 | 103 | 2.080 |
Why?
| | Eosinophilia | 8 | 2024 | 218 | 2.050 |
Why?
| | Gastritis | 5 | 2024 | 108 | 1.910 |
Why?
| | Hypersensitivity | 3 | 2022 | 257 | 1.540 |
Why?
| | Allergens | 4 | 2024 | 409 | 1.480 |
Why?
| | Eosinophilic Esophagitis | 4 | 2024 | 325 | 1.440 |
Why?
| | Intestine, Small | 2 | 2021 | 156 | 1.110 |
Why?
| | Antigen Presentation | 2 | 2018 | 218 | 0.980 |
Why?
| | Receptor, Notch2 | 1 | 2024 | 15 | 0.900 |
Why?
| | Intestines | 3 | 2024 | 357 | 0.870 |
Why?
| | Duodenitis | 1 | 2022 | 7 | 0.790 |
Why?
| | CD11 Antigens | 1 | 2022 | 30 | 0.750 |
Why?
| | Receptors, Notch | 2 | 2015 | 88 | 0.730 |
Why?
| | Signal Transduction | 7 | 2024 | 5079 | 0.720 |
Why?
| | Cytokines | 7 | 2017 | 2085 | 0.660 |
Why?
| | Mucous Membrane | 1 | 2020 | 125 | 0.630 |
Why?
| | Integrins | 1 | 2019 | 95 | 0.600 |
Why?
| | Cell Degranulation | 7 | 2017 | 41 | 0.600 |
Why?
| | Flow Cytometry | 5 | 2021 | 1178 | 0.590 |
Why?
| | Immunity, Innate | 5 | 2017 | 828 | 0.590 |
Why?
| | Th2 Cells | 2 | 2010 | 176 | 0.570 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2015 | 152 | 0.520 |
Why?
| | Receptors, IgG | 1 | 2016 | 75 | 0.510 |
Why?
| | Intestinal Mucosa | 2 | 2021 | 623 | 0.510 |
Why?
| | Immunity, Humoral | 1 | 2016 | 116 | 0.480 |
Why?
| | Adrenal Cortex Hormones | 1 | 2019 | 565 | 0.480 |
Why?
| | Environmental Exposure | 1 | 2020 | 579 | 0.470 |
Why?
| | Transendothelial and Transepithelial Migration | 1 | 2015 | 31 | 0.470 |
Why?
| | Diet Therapy | 1 | 2015 | 37 | 0.450 |
Why?
| | Immunoglobulin E | 1 | 2016 | 342 | 0.450 |
Why?
| | Diet, Reducing | 1 | 2015 | 89 | 0.440 |
Why?
| | Extracellular Traps | 3 | 2019 | 53 | 0.420 |
Why?
| | Secretory Vesicles | 5 | 2016 | 23 | 0.420 |
Why?
| | Phenotype | 3 | 2022 | 3196 | 0.410 |
Why?
| | Biomarkers | 3 | 2022 | 4149 | 0.410 |
Why?
| | Pregnancy Outcome | 1 | 2015 | 416 | 0.380 |
Why?
| | Mice | 11 | 2024 | 17787 | 0.380 |
Why?
| | Postpartum Period | 1 | 2015 | 340 | 0.370 |
Why?
| | Organ Specificity | 3 | 2020 | 305 | 0.370 |
Why?
| | Animals | 19 | 2024 | 36940 | 0.360 |
Why?
| | Interleukin-4 | 3 | 2008 | 216 | 0.360 |
Why?
| | Chemokine CCL11 | 6 | 2016 | 26 | 0.340 |
Why?
| | Autocrine Communication | 1 | 2009 | 41 | 0.300 |
Why?
| | Galectins | 2 | 2019 | 24 | 0.300 |
Why?
| | Inflammation | 5 | 2022 | 2837 | 0.300 |
Why?
| | Cytoplasmic Granules | 5 | 2017 | 93 | 0.300 |
Why?
| | Immunophenotyping | 3 | 2020 | 318 | 0.290 |
Why?
| | Mice, Inbred C57BL | 5 | 2024 | 5757 | 0.290 |
Why?
| | Th1 Cells | 1 | 2008 | 143 | 0.280 |
Why?
| | Leukocytes | 2 | 2021 | 311 | 0.280 |
Why?
| | Asthma | 1 | 2021 | 2295 | 0.270 |
Why?
| | Humans | 40 | 2024 | 137585 | 0.270 |
Why?
| | Ligands | 1 | 2009 | 664 | 0.260 |
Why?
| | Cell Differentiation | 3 | 2015 | 1991 | 0.250 |
Why?
| | Receptors, Cytokine | 1 | 2006 | 36 | 0.250 |
Why?
| | Homeostasis | 2 | 2021 | 621 | 0.240 |
Why?
| | Mice, Knockout | 3 | 2024 | 3015 | 0.230 |
Why?
| | Mice, Transgenic | 4 | 2018 | 2167 | 0.210 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2024 | 1242 | 0.210 |
Why?
| | Bile Acids and Salts | 1 | 2024 | 200 | 0.200 |
Why?
| | Cells, Cultured | 7 | 2016 | 4193 | 0.200 |
Why?
| | Allergy and Immunology | 2 | 2024 | 43 | 0.190 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 852 | 0.190 |
Why?
| | Rare Diseases | 2 | 2024 | 104 | 0.190 |
Why?
| | Crystallization | 2 | 2019 | 143 | 0.190 |
Why?
| | CD11c Antigen | 1 | 2022 | 41 | 0.190 |
Why?
| | Food Hypersensitivity | 1 | 2024 | 183 | 0.180 |
Why?
| | Myositis | 1 | 2021 | 52 | 0.170 |
Why?
| | Adaptation, Physiological | 1 | 2024 | 553 | 0.170 |
Why?
| | Leukocyte Count | 1 | 2021 | 329 | 0.160 |
Why?
| | Tetraspanin 30 | 3 | 2016 | 10 | 0.160 |
Why?
| | Cell Separation | 1 | 2021 | 318 | 0.160 |
Why?
| | Mice, Inbred BALB C | 4 | 2016 | 1272 | 0.160 |
Why?
| | Rheumatology | 1 | 2021 | 118 | 0.160 |
Why?
| | Cell Death | 2 | 2018 | 374 | 0.150 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2021 | 213 | 0.150 |
Why?
| | Disease Susceptibility | 1 | 2020 | 347 | 0.140 |
Why?
| | Exocytosis | 2 | 2016 | 89 | 0.140 |
Why?
| | Immunoglobulin G | 1 | 2022 | 893 | 0.140 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2018 | 15 | 0.140 |
Why?
| | Antigen-Presenting Cells | 1 | 2018 | 156 | 0.140 |
Why?
| | Fluorescent Antibody Technique | 1 | 2018 | 390 | 0.130 |
Why?
| | Eosinophil Granule Proteins | 2 | 2007 | 21 | 0.130 |
Why?
| | In Vitro Techniques | 3 | 2009 | 1092 | 0.130 |
Why?
| | Disease Models, Animal | 4 | 2024 | 4295 | 0.130 |
Why?
| | Advisory Committees | 1 | 2018 | 219 | 0.130 |
Why?
| | Ovalbumin | 1 | 2016 | 183 | 0.130 |
Why?
| | Health Services Needs and Demand | 1 | 2018 | 273 | 0.130 |
Why?
| | Lung Diseases | 2 | 2020 | 767 | 0.120 |
Why?
| | Antigens | 2 | 2016 | 357 | 0.120 |
Why?
| | Gastroenterology | 1 | 2018 | 180 | 0.120 |
Why?
| | Microscopy, Electron, Transmission | 6 | 2015 | 156 | 0.120 |
Why?
| | Sarcoidosis | 1 | 2018 | 159 | 0.120 |
Why?
| | Adaptive Immunity | 1 | 2016 | 165 | 0.120 |
Why?
| | Receptor, Notch1 | 1 | 2015 | 64 | 0.110 |
Why?
| | Eosinophil Major Basic Protein | 3 | 2009 | 7 | 0.110 |
Why?
| | Models, Animal | 1 | 2016 | 384 | 0.110 |
Why?
| | Respiratory Hypersensitivity | 1 | 2015 | 69 | 0.110 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2015 | 80 | 0.110 |
Why?
| | Anti-HIV Agents | 1 | 2021 | 778 | 0.110 |
Why?
| | Adoptive Transfer | 1 | 2015 | 219 | 0.110 |
Why?
| | Inflammation Mediators | 1 | 2017 | 513 | 0.110 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2607 | 0.110 |
Why?
| | Decision Support Systems, Clinical | 1 | 2017 | 226 | 0.110 |
Why?
| | Lung Diseases, Interstitial | 1 | 2021 | 638 | 0.110 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2019 | 804 | 0.110 |
Why?
| | Decision Support Techniques | 1 | 2017 | 421 | 0.100 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2021 | 657 | 0.100 |
Why?
| | MAP Kinase Signaling System | 1 | 2015 | 320 | 0.100 |
Why?
| | Microscopy, Immunoelectron | 3 | 2009 | 46 | 0.100 |
Why?
| | Machine Learning | 1 | 2017 | 493 | 0.100 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2013 | 224 | 0.100 |
Why?
| | Protein Transport | 3 | 2016 | 445 | 0.100 |
Why?
| | Life Style | 1 | 2015 | 490 | 0.090 |
Why?
| | Ribonucleases | 1 | 2012 | 55 | 0.090 |
Why?
| | Detergents | 1 | 2011 | 44 | 0.090 |
Why?
| | Chemokines, CC | 3 | 2006 | 33 | 0.090 |
Why?
| | Cytoplasm | 2 | 2016 | 274 | 0.090 |
Why?
| | Body Weight | 1 | 2015 | 985 | 0.080 |
Why?
| | Health | 1 | 2010 | 84 | 0.080 |
Why?
| | Gene Expression | 1 | 2015 | 1502 | 0.080 |
Why?
| | Helminths | 1 | 2010 | 9 | 0.080 |
Why?
| | Helminthiasis | 1 | 2010 | 12 | 0.080 |
Why?
| | Algorithms | 1 | 2017 | 1704 | 0.080 |
Why?
| | Lung | 2 | 2020 | 4060 | 0.080 |
Why?
| | Disease | 1 | 2010 | 98 | 0.080 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2011 | 367 | 0.080 |
Why?
| | RNA, Messenger | 1 | 2017 | 2833 | 0.080 |
Why?
| | Pregnancy Complications | 1 | 2015 | 527 | 0.080 |
Why?
| | Centrifugation, Density Gradient | 1 | 2009 | 41 | 0.080 |
Why?
| | Receptors, Immunologic | 1 | 2010 | 216 | 0.080 |
Why?
| | Cell Fractionation | 1 | 2009 | 56 | 0.080 |
Why?
| | Jagged-2 Protein | 1 | 2009 | 1 | 0.080 |
Why?
| | Soluble N-Ethylmaleimide-Sensitive Factor Attachment Proteins | 1 | 2009 | 4 | 0.080 |
Why?
| | Serrate-Jagged Proteins | 1 | 2009 | 27 | 0.080 |
Why?
| | Female | 7 | 2021 | 73304 | 0.080 |
Why?
| | Hypereosinophilic Syndrome | 2 | 2024 | 11 | 0.080 |
Why?
| | Endopeptidases | 1 | 2009 | 90 | 0.070 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2015 | 1477 | 0.070 |
Why?
| | Receptors, Chemokine | 2 | 2006 | 47 | 0.070 |
Why?
| | Organelles | 1 | 2008 | 58 | 0.070 |
Why?
| | Interferon-gamma | 2 | 2008 | 789 | 0.070 |
Why?
| | Peptide Hydrolases | 1 | 2009 | 111 | 0.070 |
Why?
| | Immunity, Cellular | 1 | 2010 | 268 | 0.070 |
Why?
| | Incidence | 1 | 2015 | 2804 | 0.070 |
Why?
| | Quality of Life | 1 | 2020 | 2892 | 0.070 |
Why?
| | DNA-Binding Proteins | 1 | 2015 | 1502 | 0.070 |
Why?
| | Interleukin-13 | 1 | 2008 | 149 | 0.070 |
Why?
| | Calcium-Binding Proteins | 1 | 2009 | 218 | 0.070 |
Why?
| | Retrospective Studies | 2 | 2022 | 15657 | 0.070 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2009 | 382 | 0.070 |
Why?
| | Transcription Factors | 1 | 2015 | 1719 | 0.070 |
Why?
| | HIV Infections | 1 | 2021 | 2836 | 0.060 |
Why?
| | Receptors, Interleukin-4 | 1 | 2006 | 16 | 0.060 |
Why?
| | Receptors, CCR3 | 1 | 2006 | 8 | 0.060 |
Why?
| | Receptors, Interleukin-6 | 1 | 2006 | 43 | 0.060 |
Why?
| | DNA | 1 | 2013 | 1459 | 0.060 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2009 | 455 | 0.060 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2008 | 385 | 0.060 |
Why?
| | Intracellular Membranes | 1 | 2005 | 84 | 0.060 |
Why?
| | Cell Survival | 1 | 2009 | 1120 | 0.060 |
Why?
| | Enzyme Inhibitors | 1 | 2009 | 840 | 0.060 |
Why?
| | Avidin | 1 | 2005 | 2 | 0.060 |
Why?
| | Skin | 2 | 2018 | 752 | 0.060 |
Why?
| | Sepharose | 1 | 2005 | 34 | 0.060 |
Why?
| | Child | 2 | 2022 | 21935 | 0.060 |
Why?
| | Gels | 1 | 2005 | 80 | 0.060 |
Why?
| | Ileitis | 1 | 2024 | 32 | 0.060 |
Why?
| | Staining and Labeling | 1 | 2005 | 150 | 0.060 |
Why?
| | Biological Therapy | 1 | 2024 | 29 | 0.050 |
Why?
| | Ileum | 1 | 2024 | 119 | 0.050 |
Why?
| | Cholangitis, Sclerosing | 1 | 2024 | 75 | 0.050 |
Why?
| | Exercise | 1 | 2015 | 2057 | 0.050 |
Why?
| | Congresses as Topic | 1 | 2024 | 233 | 0.050 |
Why?
| | Antibodies | 1 | 2005 | 410 | 0.050 |
Why?
| | Brugia pahangi | 1 | 2002 | 1 | 0.050 |
Why?
| | Brugia malayi | 1 | 2002 | 2 | 0.050 |
Why?
| | Filariasis | 1 | 2002 | 3 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2009 | 1164 | 0.050 |
Why?
| | Peritoneal Cavity | 1 | 2002 | 32 | 0.050 |
Why?
| | Cell Membrane | 2 | 2018 | 738 | 0.050 |
Why?
| | Liver Cirrhosis | 1 | 2024 | 316 | 0.050 |
Why?
| | Langerhans Cells | 1 | 2001 | 12 | 0.050 |
Why?
| | Pregnancy | 1 | 2015 | 6763 | 0.050 |
Why?
| | Dermis | 1 | 2001 | 33 | 0.050 |
Why?
| | Obesity | 1 | 2015 | 2992 | 0.040 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2001 | 85 | 0.040 |
Why?
| | Biological Transport | 2 | 2016 | 418 | 0.040 |
Why?
| | Emtricitabine | 1 | 2021 | 175 | 0.040 |
Why?
| | United States | 3 | 2024 | 14841 | 0.040 |
Why?
| | Quality-Adjusted Life Years | 1 | 2020 | 113 | 0.040 |
Why?
| | Protein Binding | 1 | 2006 | 2224 | 0.040 |
Why?
| | Tertiary Healthcare | 1 | 2018 | 33 | 0.040 |
Why?
| | Brefeldin A | 2 | 2008 | 10 | 0.030 |
Why?
| | Platelet Membrane Glycoproteins | 2 | 2009 | 36 | 0.030 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2018 | 128 | 0.030 |
Why?
| | Immunohistochemistry | 2 | 2017 | 1738 | 0.030 |
Why?
| | Abdomen | 1 | 2018 | 125 | 0.030 |
Why?
| | Joint Diseases | 1 | 2018 | 60 | 0.030 |
Why?
| | Single-Blind Method | 1 | 2017 | 282 | 0.030 |
Why?
| | Eye Diseases | 1 | 2018 | 87 | 0.030 |
Why?
| | Eye | 1 | 2018 | 108 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2020 | 591 | 0.030 |
Why?
| | Europe | 1 | 2018 | 414 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2017 | 283 | 0.030 |
Why?
| | Genetic Markers | 1 | 2017 | 344 | 0.030 |
Why?
| | Forced Expiratory Volume | 1 | 2018 | 531 | 0.030 |
Why?
| | Skin Diseases | 1 | 2018 | 149 | 0.030 |
Why?
| | Liver | 1 | 2024 | 1943 | 0.030 |
Why?
| | Regulatory Factor X Transcription Factors | 1 | 2015 | 11 | 0.030 |
Why?
| | X-Box Binding Protein 1 | 1 | 2015 | 10 | 0.030 |
Why?
| | Adult | 2 | 2018 | 37929 | 0.030 |
Why?
| | Granulocyte Precursor Cells | 1 | 2015 | 9 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2020 | 546 | 0.030 |
Why?
| | Lymph Nodes | 1 | 2018 | 491 | 0.030 |
Why?
| | Oxygen | 1 | 2020 | 931 | 0.030 |
Why?
| | Acute Disease | 1 | 2018 | 1007 | 0.030 |
Why?
| | Endoribonucleases | 1 | 2015 | 81 | 0.030 |
Why?
| | Health Personnel | 1 | 2021 | 710 | 0.030 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2015 | 110 | 0.030 |
Why?
| | Male | 5 | 2024 | 67762 | 0.030 |
Why?
| | Antigens, CD | 2 | 2009 | 521 | 0.030 |
Why?
| | Microscopy, Confocal | 1 | 2015 | 325 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 976 | 0.030 |
Why?
| | Sensitivity and Specificity | 1 | 2017 | 1946 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2015 | 730 | 0.020 |
Why?
| | Genotype | 1 | 2018 | 1916 | 0.020 |
Why?
| | Extracellular Space | 1 | 2013 | 119 | 0.020 |
Why?
| | Cell-Free System | 1 | 2012 | 53 | 0.020 |
Why?
| | Membranes, Artificial | 1 | 2011 | 72 | 0.020 |
Why?
| | Registries | 1 | 2017 | 2035 | 0.020 |
Why?
| | Triiodobenzoic Acids | 1 | 2009 | 9 | 0.020 |
Why?
| | Biological Transport, Active | 1 | 2009 | 77 | 0.020 |
Why?
| | Subcellular Fractions | 1 | 2009 | 82 | 0.020 |
Why?
| | Proteoglycans | 1 | 2009 | 107 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 2057 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2015 | 1774 | 0.020 |
Why?
| | Cell Compartmentation | 1 | 2007 | 52 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2009 | 402 | 0.020 |
Why?
| | Blood Proteins | 1 | 2009 | 252 | 0.020 |
Why?
| | Microscopy, Electron | 1 | 2007 | 443 | 0.020 |
Why?
| | Chemokines | 1 | 2007 | 228 | 0.020 |
Why?
| | Blotting, Western | 1 | 2008 | 1226 | 0.020 |
Why?
| | Chemotactic Factors, Eosinophil | 1 | 2005 | 7 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2009 | 1353 | 0.020 |
Why?
| | Chemokine CCL5 | 1 | 2005 | 43 | 0.020 |
Why?
| | Platelet Activating Factor | 1 | 2005 | 76 | 0.020 |
Why?
| | Forecasting | 1 | 2007 | 389 | 0.020 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2005 | 47 | 0.010 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2011 | 1091 | 0.010 |
Why?
| | Infant | 1 | 2017 | 9465 | 0.010 |
Why?
| | Child, Preschool | 1 | 2017 | 11074 | 0.010 |
Why?
| | Molting | 1 | 2002 | 9 | 0.010 |
Why?
| | Immunocompetence | 1 | 2002 | 42 | 0.010 |
Why?
| | Chemokine CCL20 | 1 | 2001 | 5 | 0.010 |
Why?
| | Receptors, CCR6 | 1 | 2001 | 4 | 0.010 |
Why?
| | Macrophage Inflammatory Proteins | 1 | 2001 | 11 | 0.010 |
Why?
| | Granuloma | 1 | 2002 | 92 | 0.010 |
Why?
| | Imaging, Three-Dimensional | 1 | 2005 | 580 | 0.010 |
Why?
| | Mice, SCID | 1 | 2002 | 367 | 0.010 |
Why?
| | Chemotaxis | 1 | 2001 | 131 | 0.010 |
Why?
| | Endocytosis | 1 | 2001 | 172 | 0.010 |
Why?
| | Models, Biological | 1 | 2007 | 1783 | 0.010 |
Why?
| | Cell Division | 1 | 2001 | 794 | 0.010 |
Why?
| | Lymphocytes | 1 | 2002 | 397 | 0.010 |
Why?
| | Kinetics | 1 | 2002 | 1670 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 21513 | 0.010 |
Why?
| | Aged | 1 | 2018 | 23961 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 2001 | 1142 | 0.010 |
Why?
| | Stem Cells | 1 | 2001 | 594 | 0.010 |
Why?
| | Middle Aged | 1 | 2018 | 33479 | 0.010 |
Why?
| | Macrophages | 1 | 2002 | 1547 | 0.010 |
Why?
|
|
Spencer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|